Clinical trial

Active Immunization of Patients With Carcinoma of Oral Cavity or Oropharynx With…

NCT00377247 · University of Pittsburgh, Other · Terminated

Key facts

NCT number NCT00377247
Title Active Immunization of Patients With Carcinoma of Oral Cavity or Oropharynx With Autologous Dendritic Cells Transfected With DNA From Autologous Tumor
Official title Active Immunization of Patients With Carcinoma of Oral Cavity or Oropharynx With Autologous Dendritic Cells Transfected With DNA From Autologous Tumor (Phase I/II Study)
Lead sponsor University of Pittsburgh, Other
Status Terminated
Phase Phase 1
Study type Interventional
Conditions Primary Advanced Carcinoma of the Oral Cavity or Oropharynx, Squamous Cell Carcinoma of the Head and Neck
Intervention type Biological
Interventions autologous monocyte-derived dendritic cells (DC) transfected with DNA
Enrollment 5
Start date Apr 1, 2009
Primary completion Apr 1, 2009
Completion Apr 1, 2009
First posted Sep 18, 2006
Last update posted Jul 11, 2016
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies